Global Marburg Hemorrhagic Fever Drug Market

Global Marburg Hemorrhagic Fever Drug Market by Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa), Forecasts, 2021-2028

  • Report ID: HC-3728
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 212
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global Marburg hemorrhagic fever drug market is anticipated to expand at substantial CAGR during the forecast period, between 2021 and 2028. Marburg virus causes Marburg viral disease (MVD), which has a case fatality rate of up to 88% but can be reduced significantly with proper patient care. Marburg virus was first discovered in 1967, following simultaneous epidemic in Marburg and Frankfurt, as well as Belgrade, Serbia. The Filoviridae family includes Marburg and Ebola viruses (filovirus). The two diseases are clinically identical, despite the fact that they are caused by distinct viruses. Both illnesses are uncommon, but they have the potential to generate large-scale epidemics with substantial death rates.

Global Marburg Hemorrhagic Fever Drug Market summary

Market Trends, Drivers, Restraints, and Opportunities:

  • Increased research and developments made in the vaccine production is expected to drive the growth for the market over forecast period.
  • Rise in prevalence of chronic diseases around the world and increasing awareness about disease treatment are expected to raise the growth for the market.
  • High cost associated with the treatment of Marburg hemorrhagic fever can hamper the growth for the market up to some extent.
  • Increasing government support for research in drug is expected to act as an opportunity for the market growth.

Scope of the report:

The report on Marburg hemorrhagic fever drug market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes

Details

Report Title

Marburg Hemorrhagic Fever Drug Market - Global Industry Analysis, Growth, Size, Share, Trends And Forecast

Base Year

2020

Historic Data

2018 & 2019

Forecast Period

2021–2028

Segmentation

Types (Marburg Vaccine, AVI-7288, TKM-Marburg, and Others) Application (Clinics, Hospitals, Others)

Regional Scope

Asia Pacific, North America, Europe, Latin America, and Middle East & Africa

Report Coverage

Market scope, analysis, share, competitive analysis, growth facts, restraints, opportunities, and revenue forecast

Key Players Covered in the Report

GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc.

Marburg Hemorrhagic Fever Drug Market Segment Insights:

AVI- 7288 segment is projected to hold significant market share

In the terms of types, the market can be divided into Marburg vaccine, AVI-7288, TKM-Marburg, and Others. The AVI -7288 segment held a considerable share of the market in 2020. AVI-7288 is a positive-charged phosphorodiamidate morpholino oligomer that targets the viral messenger RNA that encodes the Marburg virus nucleoprotein. Its safety in humans has not been established. AVI-7288 has huge potential as a post exposure prophylactic for MARV infection in humans based on efficacy in nonhuman primates and pharmacokinetic studies in humans.

Global Marburg Hemorrhagic Fever Drug Market types

Hospital segment held substantial market share in 2020

Based on applications, the Marburg hemorrhagic fever drug market can be fragmented into clinics, hospitals, and others. The hospitals segment constituted a significant market share in 2020 and is projected to expand at a rapid rate during the forecast period. Treatment for Marburg hemorrhagic fever includes supportive hospital therapy, which includes balancing fluids and electrolytes, maintaining oxygen status and blood pressure, replacing lost blood and clotting components, and treating any aggravating infections.

Global Marburg Hemorrhagic Fever Drug Market application

North America dominates the global market

In terms of regions, the global market can be segregated into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The increased investment in healthcare and presence of global market players in North America is expected to drive the growth for the market in the region over the forecast period. Moreover, increasing awareness regarding chronic diseases can boost the market during the forecast period.

Global Marburg Hemorrhagic Fever Drug Market region

Segments

Segments Covered in the Report
By Types

  • Marburg Vaccine
  • AVI-7288
  • TKM-Marburg
  • Others

By Applications

  • Clinics
  • Hospitals
  • Others

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

By Key Players

  • GlaxoSmithKline plc
  • Arbutus Biopharma
  • Sarepta Therapeutics
  • Integrated BioTherapeutics, Inc

Competitive Landscape

Key players in the Marburg hemorrhagic fever drug market include GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global Marburg Hemorrhagic Fever Drug Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Marburg Hemorrhagic Fever Drug Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Marburg Hemorrhagic Fever Drug Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Marburg Hemorrhagic Fever Drug Market - Supply Chain
  4.5. Global Marburg Hemorrhagic Fever Drug Market Forecast
     4.5.1. Marburg Hemorrhagic Fever Drug Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Marburg Hemorrhagic Fever Drug Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Marburg Hemorrhagic Fever Drug Market Absolute $ Opportunity
5. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     5.3.1. Marburg Vaccine
     5.3.2. AVI-7288
     5.3.3. TKM-Marburg
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Marburg Hemorrhagic Fever Drug Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
7. North America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     7.4.1. Marburg Vaccine
     7.4.2. AVI-7288
     7.4.3. TKM-Marburg
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
8. Latin America Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     8.4.1. Marburg Vaccine
     8.4.2. AVI-7288
     8.4.3. TKM-Marburg
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
9. Europe Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     9.4.1. Marburg Vaccine
     9.4.2. AVI-7288
     9.4.3. TKM-Marburg
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
10. Asia Pacific Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     10.4.1. Marburg Vaccine
     10.4.2. AVI-7288
     10.4.3. TKM-Marburg
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
11. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Marburg Hemorrhagic Fever Drug Market Size and Volume Forecast by Types
     11.4.1. Marburg Vaccine
     11.4.2. AVI-7288
     11.4.3. TKM-Marburg
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Marburg Hemorrhagic Fever Drug Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Marburg Hemorrhagic Fever Drug Market: Market Share Analysis
  12.2. Marburg Hemorrhagic Fever Drug Distributors and Customers
  12.3. Marburg Hemorrhagic Fever Drug Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. GlaxoSmithKline plc
     12.4.2. Arbutus Biopharma
     12.4.3. Sarepta Therapeutics
     12.4.4. Integrated BioTherapeutics, Inc

Segments Covered in the Report
By Types

  • Marburg Vaccine
  • AVI-7288
  • TKM-Marburg
  • Others

By Applications

  • Clinics
  • Hospitals
  • Others

By Regions

  • North America
  • Europe
  • Latin America
  • Asia Pacific
  • Middle East & Africa

By Key Players

  • GlaxoSmithKline plc
  • Arbutus Biopharma
  • Sarepta Therapeutics
  • Integrated BioTherapeutics, Inc

Key players in the Marburg hemorrhagic fever drug market include GlaxoSmithKline plc, Arbutus Biopharma, Sarepta Therapeutics, Integrated BioTherapeutics, Inc. These players engage in mergers & acquisitions, collaborations, agreements, and partnerships to strengthen their geographical presence.

Global Marburg Hemorrhagic Fever Drug Market keyplayers

Buy Report